Domov › Kolesterol › Kalifornija
Klinične študije za Kolesterol v Kalifornija
6 študij za Kolesterol išče udeležence na lokacijah v Kalifornija.
Uradno besedilo študije (angleško)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Pacific Oaks Medical Group, Beverly Hills
- Cardiovascular Institute of San Diego, Chula Vista
- John Muir Medical Center - Concord Campus, Concord
- in še 10
Vključevanje udeležencevFaza 4
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Huntington Beach
- Research Site, Loma Linda
- Research Site, Lomita
- in še 2
Vključevanje udeležencevFaza 3
Starost 18–130 · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT07619131A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Clinical Trials Research, Lincoln
- Downtown L A Research Center Inc, Los Angeles
- Valley Clinical Trials, Northridge
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 30. jul. 2026 · NCT07610278Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- UC San Francisco Medical Center, San Francisco
Vključevanje udeležencevFaza 3
Starost 2–11 · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT06597006A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Anaheim Clinical Trials, Anaheim
- Cenexel CNS, Los Alamitos
- Diablo Clinical Research - Flourish Research, Walnut Creek
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT07477704Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- UC San Francisco Medical Center, San Francisco
- UC San Francisco Medical Center, San Francisco
Vključevanje udeležencevFaza 3
Starost 6–11 · Vsi spoli · Posodobljeno 15. maj 2026 · NCT06597019Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.